Author: SA News | Category: In The News | Biomedical Engineering (Ph.D.) | January 02, 2018
Dr. Jean Jiang, lead principal investigator on the project and a professor of biochemistry and structural anatomy at UT Health San Antonio was featured in the San Antonio Express News for her work regarding antibodies. According to the article, UT Health San Antonio received $3.2 million of those funds to conduct preclinical testing of a therapeutic antibody.
"There are some drugs on the market for breast cancer bone metastasis, but more are needed, said Jiang," who is also the associate director of the Joint Biomedical Engineering Graduate Program of UT Health San Antonio and the University of Texas at San Antonio.
Published 6:54 pm, Thursday, December 21, 2017 Scientists at University of Texas medical institutions in San Antonio and Houston have received a $6 million grant to test and help develop a drug aimed at keeping breast cancer from further invading bone tissue, the health establishments revealed Thursday.
Copyright © 2019 The University of Texas Health Science Center at San Antonio
Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.